A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions
Phase of Trial: Phase IV
Latest Information Update: 03 Jul 2019
At a glance
- Drugs Umirolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- Acronyms EuroCTO
- 01 Mar 2019 Status changed from active, no longer recruiting to completed.
- 02 May 2018 Primary endpoint (Quality of Life) has been met, according to the results published in the European Heart Journal.
- 02 May 2018 Results published in the European Heart Journal.